MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 05-16-2026
Atrion Corporation Operating Cash Flow 2011-2026 | ATRI
Annual Operating Cash Flow Atrion Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 K | 28.8 K | 38.8 K | 39.2 M | 42.5 M | 43.2 M | 47 M | 37.4 M | 40.4 M | 31.2 M | 36.6 M | 29.4 M | 31.5 M | 31.1 M | 28.4 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 47 M | 20 K | 29.2 M |
Quarterly Operating Cash Flow Atrion Corporation
| 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.5 M | 11.5 M | 9.15 M | 3.73 M | 4.33 M | - | 28.9 M | 18.3 M | 11.8 M | - | 28.8 M | 16 M | 7.4 M | - | 28.7 M | 19.4 M | 12.8 M | - | 36.2 M | 24.1 M | 12.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 27.4 M | 16.5 M | 8.08 M | - | 23.4 M | 10.9 M | 4.94 M | - | 23.5 M | 13.2 M | 7.37 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 36.2 M | 3.73 M | 16.6 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
796 M | $ 65.05 | -3.41 % | $ 13 B |  USA |
 |
Glaukos Corporation
GKOS
|
-14.8 M | $ 127.41 | -0.09 % | $ 7.29 B | USA |
 |
Alcon
ALC
|
1.34 B | $ 64.14 | -2.58 % | $ 40.4 B |  Schweiz |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 402.18 | -3.57 % | $ 144 B | USA |
 |
ICU Medical
ICUI
|
180 M | $ 137.94 | -3.14 % | $ 3.4 B | USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 101.79 | -6.48 % | $ 3.26 B | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 92.21 | -1.26 % | $ 2.09 B | USA |
 |
Repro Med Systems
KRMD
|
462 K | $ 3.88 | -1.52 % | $ 179 M | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 179.95 | - | $ 9.59 B | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 65.24 | -3.61 % | $ 3.86 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | - | - | $ 28.6 M | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 1.88 | 3.3 % | $ 86.1 M |  Israel |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.34 | -0.03 % | $ 27.9 M | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 8.7 | 0.23 % | $ 73.8 K | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 24.86 | 0.44 % | $ 4.18 B | USA |
 |
Haemonetics Corporation
HAE
|
293 M | $ 72.73 | -2.3 % | $ 3.43 B | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 29.22 | 1.04 % | $ 1.45 B | USA |
 |
STERIS plc
STE
|
1.34 B | $ 199.4 | -3.44 % | $ 19.6 B | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
InfuSystem Holdings
INFU
|
24.4 M | $ 8.75 | -1.46 % | $ 181 M | USA |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 65.7 | -2.17 % | $ 213 M | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 323.59 | -1.82 % | $ 23.4 B | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 25.45 | 1.35 % | $ 1.72 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 10.03 | -4.02 % | $ 2 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.67 | 1.48 % | $ 20.1 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 60.46 | -2.98 % | $ 199 M | USA |
 |
Predictive Oncology
POAI
|
-13.2 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
20.1 M | $ 25.58 | -2.96 % | $ 1.22 B | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.78 | -2.2 % | $ 162 M | USA |
 |
Baxter International
BAX
|
845 M | $ 19.39 | -5.37 % | $ 9.95 B | USA |
 |
ResMed
RMD
|
351 M | $ 186.29 | -3.92 % | $ 27.2 B | USA |
 |
AtriCure
ATRC
|
57.3 M | $ 27.12 | -3.07 % | $ 1.29 B | USA |
 |
Harvard Bioscience
HBIO
|
6.73 M | $ 6.0 | 0.84 % | $ 266 M | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 11.74 | -3.37 % | $ 480 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 141.61 | -2.44 % | $ 40.7 B | USA |
 |
Nephros
NEPH
|
1.64 M | $ 3.2 | 0.31 % | $ 34 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 4.47 | 3.47 % | $ 328 M | USA |
 |
Repligen Corporation
RGEN
|
117 M | $ 133.55 | 1.41 % | $ 7.51 M | USA |